Innovating Works

H2020

Cerrada
HORIZON-INFRA-2023-EOSC-01-04
Next generation services for operational and sustainable EOSC Core Infrastructure
ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes:
Sólo fondo perdido 10.0M €
Europeo
Mostrando 381 al 387 de 387 resultados
VMS - Vaginal Microbiome Screening: Commercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon col... TAMPONENI INOVATSII OOD tramitó un HORIZON EUROPE: HORIZON-EIC-2023-ACCELERATOR-01 VMS is a home-based gynaecological test kit, using a menstrual tampon for sample collection. VMS will improve the accuracy and convenience w...
2023-06-28 - 2025-06-30 | Financiado
Digitising Hospitals For Better Patient Care: First modular, interconnected, data- and AI-driven software platform for the digitisation of patient... AVELIOS MEDICAL GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2023-ACCELERATOR-01 In Europe, there are 36.6 doctors and 83.3 nurses per 10,000 inhabitants. Both professional groups spend 169 minutes of their working time e...
2023-06-20 - 2025-06-30 | Financiado
OCEANBATTERY: Unlocking the full potential of renewable energy with the Ocean Battery OCEAN GRAZER BV tramitó un HORIZON EUROPE: HORIZON-EIC-2023-ACCELERATOR-01 The Ocean Battery is a CES Best-of-Innovation Award winning breakthrough solution based on proprietary Key Enabling Technology to solve the...
2023-06-20 - 2025-06-30 | Financiado
COMFTQUA: Enabling efficient computation on fault tolerant quantum computers BEIT SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA tramitó un HORIZON EUROPE: HORIZON-EIC-2023-ACCELERATOR-01 Our solution is an innovative suite of hardware-agnostic quantum algorithms, along with their hardware-aware implementations. Our solution w...
2023-06-16 - 2025-06-30 | Financiado
Bac3Gel: New generation of substrates to harness the full power of microorganisms BAC3GEL LDA. tramitó un HORIZON EUROPE: HORIZON-EIC-2023-ACCELERATOR-01 Bac3Gel is a biotech company that develops and distributes advanced substrates to harness the full power of microorganisms. Bac3Gel substra...
2023-06-07 - 2025-06-30 | Financiado
Endoprotease 40 (E40): First ever preventive treatment for celiac disease and gluten sensitivity NEMYSIS LIMITED tramitó un HORIZON EUROPE: HORIZON-EIC-2023-ACCELERATOR-01 E40 is a novel gluten degrading enzyme aimed at enhancing the degradation of ingested gluten, particularly in gluten intolerant Celiac Disea...
2023-05-18 - 2025-05-31 | Financiado
WHYLD: Worlwide HYdrological Large-scale Database VORTEX.IO tramitó un HORIZON EUROPE: HORIZON-EIC-2023-ACCELERATOR-01 VorteX.io offers an innovative and intelligent service for monitoring hydrological surfaces, using in-situ remote sensing instruments, based...
2023-05-11 - 2025-06-30 | Financiado